Underlying inflammation may cause higher rates of CV events
Black patients less likely to receive advanced therapies
Results from an artificial intelligence model
Study further validates the role of biologics in improving outcomes
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Management pearls from a new expert review
Too few patients assessed before undergoing biologic dose changes
Exciting developments continue
Presentations, hot topics, and cases with masters
Beyond bisphosphonates
Hepatitis B reactivation a concern